Answers are grounded in this paper and cite their sources.
Brolucizumab (Beovu™) has been the most talked about anti-VEGF molecule since its launch due to the various twists and turns caused by drug-induced intraocular inflammation (IOI). The drug received...
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: